Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Boston Medical Group

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Boston Medical Group head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 187 · Grade C

Boston Medical Group

Visit Boston Medical Group Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Boston Medical Group a bad call — it's best for readers who want a physician consultation and will resolve the conflicting program prices before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
88
Access Breadth
93
46
Clinical Oversight
92
82
Track Record
88
77
CoreAge RxBrief Score 94 · 68Boston Medical Group

Price, coverage & the tracker

CoreAge RxBoston Medical Group
Brief Score94/100 (A)68/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm twelve-week total

Public pages give conflicting $699/$999 totals; prescribed formulation, dose and platform fees need a reconciled quote.

Full price details

Current semaglutide formulation and complete program quote unknown; conflicting twelve-week totals $699/$999; earlier listing: From $199/mo (starting strength, rising with dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm a named-drug quote

A general FAQ mention does not establish a current tirzepatide formulation, plan or complete charge.

Full price details

Current tirzepatide plan and medication quote unknown; earlier listing: Not disclosed

CoverageUS only; restrictions by state, confirmed at intakeService depends on a clinician licensed where you receive care; confirm current program availability in your state
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Boston Medical Group: Cost page lists $699 for twelve weeks; program-steps page lists $999 including a $100 platform fee. Obtain the applicable written quote.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.